|
|
| Cliniques Privées > Etude de marché sectorielle |
| Next Generation Drugs: Acceleration Through Innovation |
|
|
|
|
€ 953,48 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Mars 2002 |
Taille du document : |
242 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 56 pages | Février 2007 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
pricing policy,market definition, |
| Geographic
focus: |
australia,france,usa,spain,ireland,italy,... |
| |
|
|
|
|
| 158 pages | Juin 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
industry structure,distribution channels, |
| Geographic
focus: |
usa,france,china,italy,japan,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Medical Laboratories Industry
230 pages | Décembre 1999 |
This Marketdata report examines the $34+ billion test market for: cholesterol, PAP, AIDS, drug abuse screening and other tests.
This study offers analysis and market share information on indepe |
1 400,00 €
|
| |
| |
The UK Hospital Supplies Market
70 pages | Mars 2002 |
This report will enable you to:Analyse the size of the UK market for hospital supplies between 1997 and 2006Quantify the size of the UK medical equipment market by the following sectors: -medical &am |
886,00 €
|
| |
| |
Homes For The Elderly: Wales
60 pages | Juin 2000 |
The Welsh Presentation Includes:- Number Of Residential Homes In Wales, 1997-2004- Number Of Residential Homes In Wales By Health Authority & Sector - Number Of Places In Residential Homes In Wale |
243,15 €
|
| |
| |
Medical Back Office Management
149 pages | Octobre 2006 |
Medical Back Office Management |
55,00 €
|
| |
| |
Private Healthcare
99 pages | Mars 2001 |
Analyse the reasons behind the changes in demand for private healthcare in the UK over the next 5 years
· Examine the main factors affecting demand
· Target the sectors with |
628,85 €
|
| |
| |
Private Hospital Services in Indonesia
29 pages | Janvier 2006 |
This report consists of establishments mainly engaged in providing hospital facilities, continuous out and in-patient nursing care covering children's diseases, eye, dental, ear- nose-throat diseases, |
385,00 €
|
| |
| |
Next Generation Drugs: Acceleration Through Innovation
242 pages | Mars 2002 |
The pharmaceutical industry is now immersed in a wave of technological innovation to help accelerate drug discovery and development.
However, selecting the most beneficial technological systems to |
953,48 €
|
| |
| |
Emergency Care Management:
79 pages | Octobre 2006 |
Emergency Care Management: |
47,00 €
|
| |
| |
Homes For The Elderly: Northern Ireland
48 pages | Juin 2000 |
The Northern Ireland Presentation Includes: - Number Of Residential Homes In Northern Ireland, By HSS Trust Area- Number Of Places In Residential Homes In Northern Ireland, By HSS Trust Area- Occupan |
243,15 €
|
| |
| |
Fertility Clinics and Adoption Services: An Industry Analysis
147 pages | Septembre 2000 |
This pioneering new analysis by Marketdata examines the growing ``baby business`` in the U.S.-services provided by fertility clinics (assisted reproductive technology), adoption agencies, and surr |
1 500,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Next Generation Drugs: Acceleration Through Innovation |
|
|
The pharmaceutical industry is now immersed in a wave of technological innovation
to help accelerate drug discovery and development. However, selecting the most
beneficial technological systems to reduce discovery and development timelines
involves due consideration of a company's R&D focus, pipeline commitments,
synergies to enhance R&D programmes, and analysis of risk and competition.
Next Generation Drugs: Acceleration through innovation is a new management report
examining the technological innovations that are being employed by the pharmaceutical
majors to expedite discovery research and R&D. Key areas of review include
genomics, proteomics, pharmacogenomics, bioinformatics, and cheminformatics in
addition to other key enabling high technology discovery and development platforms.
This new report also reviews how companies are accelerating discovery through
strategic collaborations, enhancement of in-house expertise, and by focusing on
specific diseases or small molecules to optimize their future business plans.
|
|
EXECUTIVE SUMMARY CHAPTER 1: INTRODUCTION TO NEXT GENERATION DRUGS
• Drug discovery - past, present, and future
• Internal and external drivers of pharmaceutical innovation
• Pharmaceutical R&D:
• The importance of bioinformatics and knowledge management in accelerating drug discovery
• Leaders in the pharmaceutical bioinformatics industry
• Effect of bioinformatics on the drug discovery process
CHAPTER 2: TECHNOLOGICAL INNOVATIONS IN THE PHARMACEUTICAL INDUSTRY
• Reducing the discovery timeline to accelerate first-to-market advantage
• Genomics
• Proteomics
• Combinatorial Chemistry
• Pharmacogenomics
• Technological platforms - past, present, and future
CHAPTER 3: ACCELERATING DRUG DISCOVERY AND DEVELOPMENT
• Novel technology platforms Bioinformatics and supercomputing
• The demand for improved efficiency
• Bioinformatics to improve target selection
• Novel high technology discovery ,and development solutions
• Informatics/software applications
• Supercomputing
• Analytic and screening technologies
• Information management solutions to accelerate time to market
• First Consulting Group/Aventis
CHAPTER 4: ACTIVITIES & STRATEGIES TO ACCELERATE ,DISCOVERY R&D
CHAPTER 5: THE OUTLOOK FOR NEXT GENERATION DRUGS
• Genomics - The key to Next Generation Drugs
• Next Generation Drug targets
• Growth in the drug discovery sector
• Innovation to accelerate drug discovery
• The importance of high technologies for future drug discovery
• Technologies with increased importance in 2005
• Pharmacogenomics
• Genetic testing of disease
• Leading pharma companies ,accelerating drug discovery
• New frontiers in healthcare
|
|
|
PPLSEN
|
|
|
|
|
